Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie J Calvert

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Nature Reviews. Drug Discovery|October 2, 2019
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomesMelanie J Calvert, Daniel J O'Connor, Ethan M Basch
Revista Espanola De Cardiologia|November 13, 2010
Cardiac resynchronisation therapy is cost effectiveMelanie J Calvert, Nick Freemantle, John G F Cleland
Journal of the American Chemical Society|September 26, 2002
Germacrene A is a product of the aristolochene synthase-mediated conversion of farnesylpyrophosphate to aristolocheneMelanie J Calvert, Peter R Ashton, Rudolf K Allemann
Lancet (London, England)|September 21, 2019
Extension of the CONSORT and SPIRIT statementsXiaoxuan Liu, Livia Faes, Melanie J Calvert, et al.
American Heart Journal|March 3, 2009
Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) studyJohn G F Cleland, Melanie J Calvert, Yves Verboven, et al.
BJGP Open|November 17, 2020
Implementing PROMs in routine clinical care: a qualitative exploration of GP perspectivesIan Litchfield, Sheila Greenfield, Grace M Turner, et al.
Family Practice|January 21, 2009
Evaluation of the management of heart failure in primary careMelanie J Calvert, Aparna Shankar, Richard J McManus, et al.
Orphanet Journal of Rare Diseases|April 18, 2023
"I just wanted to speak to someone- and there was no one…": using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipientsIan Litchfield, Melanie J Calvert, Francesca Kinsella, et al.
The Lancet. Digital Health|December 17, 2020
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extensionXiaoxuan Liu, Samantha Cruz Rivera, David Moher, et al.
European Heart Journal|June 2, 2007
Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trialMatthew Richardson, Nick Freemantle, Melanie J Calvert, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Nature Reviews. Drug Discovery|October 2, 2019
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomesMelanie J Calvert, Daniel J O'Connor, Ethan M Basch
Revista Espanola De Cardiologia|November 13, 2010
Cardiac resynchronisation therapy is cost effectiveMelanie J Calvert, Nick Freemantle, John G F Cleland
Journal of the American Chemical Society|September 26, 2002
Germacrene A is a product of the aristolochene synthase-mediated conversion of farnesylpyrophosphate to aristolocheneMelanie J Calvert, Peter R Ashton, Rudolf K Allemann
Lancet (London, England)|September 21, 2019
Extension of the CONSORT and SPIRIT statementsXiaoxuan Liu, Livia Faes, Melanie J Calvert, et al.
American Heart Journal|March 3, 2009
Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) studyJohn G F Cleland, Melanie J Calvert, Yves Verboven, et al.
BJGP Open|November 17, 2020
Implementing PROMs in routine clinical care: a qualitative exploration of GP perspectivesIan Litchfield, Sheila Greenfield, Grace M Turner, et al.
Family Practice|January 21, 2009
Evaluation of the management of heart failure in primary careMelanie J Calvert, Aparna Shankar, Richard J McManus, et al.
Orphanet Journal of Rare Diseases|April 18, 2023
"I just wanted to speak to someone- and there was no one…": using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipientsIan Litchfield, Melanie J Calvert, Francesca Kinsella, et al.
The Lancet. Digital Health|December 17, 2020
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extensionXiaoxuan Liu, Samantha Cruz Rivera, David Moher, et al.
European Heart Journal|June 2, 2007
Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trialMatthew Richardson, Nick Freemantle, Melanie J Calvert, et al.
Pageof 9